BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32990004)

  • 1. Alzheimer's drug Memantine inhibits metastasis and p-Erk protein expression on 4T1 breast cancer cells.
    Albayrak G; Korkmaz FD
    Bratisl Lek Listy; 2020; 121(7):499-503. PubMed ID: 32990004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memantine induces apoptosis and inhibits cell cycle progression in LNCaP prostate cancer cells.
    Albayrak G; Konac E; Dikmen AU; Bilen CY
    Hum Exp Toxicol; 2018 Sep; 37(9):953-958. PubMed ID: 29226720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumorigenic Effect of Memantine via Interfering Glutamate Metabolism in Mouse 4T1 Breast Tumor Model.
    Albayrak G; Korkmaz FD; Bali EB; Bagriacik EU
    Anticancer Agents Med Chem; 2021; 21(12):1575-1580. PubMed ID: 33081685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Cancer Cell Metabolism with Metformin, Dichloroacetate and Memantine in Glioblastoma (GBM).
    Albayrak G; Konac E; Dere UA; Emmez H
    Turk Neurosurg; 2021; 31(2):233-237. PubMed ID: 33372258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
    Lipton SA
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism.
    Lipton SA
    Curr Alzheimer Res; 2005 Apr; 2(2):155-65. PubMed ID: 15974913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memantine ameliorates depressive-like behaviors by regulating hippocampal cell proliferation and neuroprotection in olfactory bulbectomized mice.
    Takahashi K; Nakagawasai O; Nemoto W; Kadota S; Isono J; Odaira T; Sakuma W; Arai Y; Tadano T; Tan-No K
    Neuropharmacology; 2018 Jul; 137():141-155. PubMed ID: 29729893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of memantine for the treatment of dementia.
    Lo D; Grossberg GT
    Expert Rev Neurother; 2011 Oct; 11(10):1359-70. PubMed ID: 21955192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
    Lipton SA
    Curr Drug Targets; 2007 May; 8(5):621-32. PubMed ID: 17504105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-autophagic and anti-apoptotic effects of memantine in a SH-SY5Y cell model of Alzheimer's disease via mammalian target of rapamycin-dependent and -independent pathways.
    Song G; Li Y; Lin L; Cao Y
    Mol Med Rep; 2015 Nov; 12(5):7615-22. PubMed ID: 26459718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidiabetic drug metformin induces apoptosis in human MCF breast cancer via targeting ERK signaling.
    Malki A; Youssef A
    Oncol Res; 2011; 19(6):275-85. PubMed ID: 21776823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mémantine (Ebixa): a new therapeutic strategy for the treatment of moderate to severe forms of Alzheimer's disease].
    Gallarda T; Lôo H
    Encephale; 2004; 30(1):69-79. PubMed ID: 15029079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memantine facilitates memory consolidation and reconsolidation in the day-old chick.
    Samartgis JR; Schachte L; Hazi A; Crowe SF
    Neurobiol Learn Mem; 2012 May; 97(4):380-5. PubMed ID: 22425751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memantine shifts cancer cell metabolism via AMPK1/2 mediated energetic switch in A549 lung cancer cells.
    Albayrak G; Demirtas Korkmaz F
    EXCLI J; 2021; 20():223-231. PubMed ID: 34121969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein tyrosine kinase, JNK, and ERK involvement in pseudolaric acid B-induced apoptosis of human breast cancer MCF-7 cells.
    Yu JH; Wang HJ; Li XR; Tashiro S; Onodera S; Ikejima T
    Acta Pharmacol Sin; 2008 Sep; 29(9):1069-76. PubMed ID: 18718176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
    Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
    J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yulangsan polysaccharide inhibits 4T1 breast cancer cell proliferation and induces apoptosis in vitro and in vivo.
    Qin N; Lu S; Chen N; Chen C; Xie Q; Wei X; Ye F; He J; Li Y; Chen L; Jiang L; Lu X; Yuan Y; Li J; Jiao Y; Huang R
    Int J Biol Macromol; 2019 Jan; 121():971-980. PubMed ID: 30340007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.
    Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB
    Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic dose-sparing effect with addition of memantine.
    Sleeper RB
    Ann Pharmacother; 2005 Sep; 39(9):1573-6. PubMed ID: 16076907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memantine for treatment of moderate to severe Alzheimer's disease.
    Perras C
    Issues Emerg Health Technol; 2005 Mar; (64):1-4. PubMed ID: 15762015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.